We are live on
!
Find out more
AAP
Arax Advisory Partners Portfolio holdings
AUM
$3.54B
1-Year Est. Return
19.14%
This Fund
S&P 500
This Quarter
Est. Return
+8.62%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
–
AUM
$6.97B
AUM Growth
+$4.79B
(+220%)
Cap. Flow
+$6.91B
Cap. Flow
% of AUM
99.25%
Top 10 Holdings %
Top 10 Hldgs %
36.51%
Holding
4,400
New
1,371
Increased
1,984
Reduced
143
Closed
794
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 100 ETF
OEF
|
+$2.43B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.24B |
| 3 |
DFAI
Dimensional International Core Equity Market ETF
DFAI
|
+$202M |
| 4 |
American Century Diversified Corporate Bond ETF
KORP
|
+$152M |
| 5 |
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Growth ETF
VUG
|
+$91.2M |
| 2 |
Vanguard Morningstar Value ETF
VTV
|
+$62.6M |
| 3 |
AXON
Axon Enterprise
AXON
|
+$58.1M |
| 4 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$46.5M |
| 5 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$44.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.48% |
| 2 | Financials | 8.05% |
| 3 | Industrials | 7.03% |
| 4 | Consumer Discretionary | 6.62% |
| 5 | Healthcare | 6.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ELVR
2976
Elevra Lithium Ltd
ELVR
$1.16B
| $3.36K | ﹤0.01% |
+140
| New | +$2.92K |
|
2977
MaxCyte
MXCT
$125M
| $3.35K | ﹤0.01% |
+2,121
| New | +$3.69K |
|
2978
Orthofix Medical
OFIX
$422M
| $3.35K | ﹤0.01% |
+229
| New | +$3.01K |
|
2979
Apogee Therapeutics
APGE
$10.2B
| $3.34K | ﹤0.01% |
84
+58
| +223% | +$2.21K |
|
2980
Sutro Biopharma
STRO
$420M
| $3.34K | ﹤0.01% |
+384
| New | +$3.27K |
|
|
CGGE
2981
Capital Group Global Equity ETF
CGGE
$3.04B
| $3.33K | ﹤0.01% |
108
| – | – |
|
2982
Green Dot
GDOT
$744M
| $3.32K | ﹤0.01% |
+247
| New | +$3.05K |
|
2983
DocGo
DCGO
$62.1M
| $3.31K | ﹤0.01% |
+2,436
| New | +$3.69K |
|
2984
BRC Inc
BRCC
$248M
| $3.3K | ﹤0.01% |
2,118
+2,018
| +2,018% | +$3.23K |
|
2985
Biote Corp
BTMD
$48.5M
| $3.3K | ﹤0.01% |
+1,101
| New | +$3.93K |
|
2986
Theravance Biopharma
TBPH
$877M
| $3.3K | ﹤0.01% |
+226
| New | +$2.86K |
|
2987
Methanex
MEOH
$4.14B
| $3.28K | ﹤0.01% |
82
+32
| +64% | +$1.14K |
|
2988
Freedom Holding
FRHC
$9.43B
| $3.27K | ﹤0.01% |
+19
| New | +$3.21K |
|
2989
National Bankshares
NKSH
$266M
| $3.27K | ﹤0.01% |
+111
| New | +$3.28K |
|
2990
HUTCHMED
HCM
$2.16B
| $3.25K | ﹤0.01% |
206
+103
| +100% | +$1.7K |
|
2991
loanDepot
LDI
$514M
| $3.23K | ﹤0.01% |
+1,053
| New | +$2.43K |
|
2992
SolarEdge
SEDG
$1.94B
| $3.22K | ﹤0.01% |
+87
| New | +$2.6K |
|
|
MRX
2993
Marex Group Limited Ordinary Shares
MRX
$4.41B
| $3.19K | ﹤0.01% |
+95
| New | +$3.43K |
|
2994
The GEO Group
GEO
$4.14B
| $3.16K | ﹤0.01% |
154
-573
| -79% | -$13.1K |
|
2995
FerroAtlántica
GSM
$856M
| $3.15K | ﹤0.01% |
+692
| New | +$2.96K |
|
2996
Enliven Therapeutics
ELVN
$4.41B
| $3.13K | ﹤0.01% |
+153
| New | +$3.08K |
|
2997
Samsara
IOT
$23.9B
| $3.13K | ﹤0.01% |
+84
| New | +$3.12K |
|
2998
Farmers & Merchants Bancorp
FMAO
$481M
| $3.13K | ﹤0.01% |
+125
| New | +$3.22K |
|
2999
GFL Environmental
GFL
$14.9B
| $3.13K | ﹤0.01% |
+66
| New | +$3.2K |
|
3000
Tonix Pharmaceuticals
TNXP
$187M
| $3.12K | ﹤0.01% |
+129
| New | +$4.79K |
|
Similar funds
TYCC
TH
BCP
WWA
VPC
BPS
TCM
DILIC
Arax Advisory Partners's Q3 2025 Portfolio in Review
As of Q3 2025, Arax Advisory Partners held 4,400 positions worth $6.97B, up 220% from $2.18B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Arax Advisory Partners deployed $6.91B of net new capital in Q3 2025, opening 1,371 new positions and adding to 1,984 existing holdings. Its largest new stake was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 6.5% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Axon Enterprise, an estimated $58.1M trimmed.
- Arax Advisory Partners's largest Q3 2025 buy was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.
- Arax Advisory Partners added most to iShares S&P 100 ETF in Q3 2025, an estimated $2.43B increase.
- Arax Advisory Partners's biggest Q3 2025 reduction was Axon Enterprise, cutting an estimated $58.1M.
- Arax Advisory Partners fully exited Vanguard Morningstar Growth ETF in Q3 2025, selling an estimated $91.2M.
- Arax Advisory Partners's ten largest holdings make up 37% of its $6.97B portfolio in Q3 2025.
- Arax Advisory Partners opened 1,371 new positions and closed 794 in Q3 2025.
- Arax Advisory Partners's portfolio value rose 220% quarter-over-quarter to $6.97B.
Based on Arax Advisory Partners's 13F filing for Q3 2025, filed 14 Nov 2025.